GeneHarbor's pipeline includes novel enzymes and processes for the production of bioethanol, biodiesel, pharmaceutical products, neutraceutical products and high-value food ingredients. The company has also developed proprietary, therapeutic and diagnostic products for human applications.

GeneHarbor's products candidates are the subjects of Chinese and international patent applications.

GeneHarbor's leading products target large, well-defined markets, each creating a value ranging US$100 million to over US$1 billon through cost saving and value added.